Table 1 Characteristics of study subjects
Characteristics | All | HIV positive patients | HIV negative patients | Household contacts | Neighborhood controls |
|---|---|---|---|---|---|
Number of study subjects | 484 | 205 | 179 | 51 | 49 |
Female (%) | 220 (45.5) | 99 (48.3) | 64 (36.0) | 33 (64.7) | 24 (49.0) |
Age median (range) | 33 (15-89) | 34 (19-70) | 32 (15-89) | 32 (18-86) | 33 (16-55) |
   Males | 36 (15-89) | 37 (23-70) | 35 (15-89) | 36 (18-60) | 32 (16-55) |
   Females | 32 (16-86) | 32 (19-60) | 30 (18-77) | 30 (18-86) | 33 (16-55) |
HIV positive (%) | 213 (44.0) | 205 (100) | 0 | 6 (11.8) | 2 (4.1) |
TB positive (%) | 250 (65.1) | 118 (57.6) | 132 (73.7) | - | - |
CD4* median (range) | 340 (21-2117) | 208 (21-926) | 387 (49-1609) | 622 (146-1714) | 465 (180-2117) |
CD4* < 200 (%) | 112 (23.1) | 94 (45.9) | 15 (8.4) | 1 (2.0) | 2 (4.1) |
Receiving presumptive antibiotic treatment (%) | 175 (46.5) | 98 (49.0) | 77 (43.8) | - | - |
Receiving presumptive curative TMX**(%) | 45 (12.3) | 35 (17.8) | 10 (5.9) | - | - |
Receiving prophylactic TMX**1 (%) | 57 (57.6) | 57 (57.6) | - | - | - |